2Xie HG,Dishy V,Sofowora G,et al.Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo.Pharmacogenetics,2001,11:191-197.
3Beta-Blocker Evaluation of Survival Trial Investigators.A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.N Engl J Med,2001,344:1659-1667.
4Gottlieb SS,McCarter R J,Vogel RA.Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarctation.N Engl J Med,1998,339:489-497.
5Bengtsson K,Melander O,Orho-Melander M,et al.Polymorphism in the beta-1 adrenergic receptor gene and hypertension.Circulation,2001,104:187-190.
6White HL,de Boer RA,Maqbool A,et al.An evaluation of the beta 1-adrenergic receptor Arg389Gly polymorphism in individuals with heart failure:a MERIT-HF sub-study.Eur J Heart Fail,2003,5:463-468.
7Iwai C,Akita H,Kanazawa K,et al.Arg389Gly polymorphism of the human beta 1-adrenergic receptor in patients with nonfatal acute myocardial infarction.Am Heart J,2003,146:106-109.
8Sandilands AJ,O'Shaughnessy KM,Brown MJ.Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors versus Gly389 beta 1-adrenoceptors in isolated human atrial myocardium.Br J Pharmacol,2003,138:386-392.
9Liu J,Liu ZQ,Tan ZR,et al.Gly389Arg polymorphism of beta 1-adrenergic receptor is associated with the cardiovascular response to metoprolol.Clin Pharmacol Ther,2003,74:372-379.
10Mialet Perez J,Rathz DA,Petrashevskaya NN,et al.Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure.Nat Med,2003,9:1300-1305.
